Lubris Overview

  • Founded
  • 2011
  • Status
  • Private
  • Employees
  • 4
  • Latest Deal Type
  • Series A
  • Investors
  • 4

Lubris General Information


Developer of a human protein designed to offer treatment of a wide variety of age and inflammation-related conditions of health. The company's protein called recombinant human lubricin is used for the treatment of dry eye, osteoarthritis, surgical adhesions, xerostomia, pericarditis and other conditions, enabling doctors to offer improved treatment for dry eye disease.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • 85 Nobscot Road
  • Weston, MA 02493
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Lubris Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 01-Jul-2013 Completed Generating Revenue
1. Accelerator/Incubator Completed Startup
To view Lubris’s complete valuation and funding history, request access »

Lubris Executive Team (7)

Name Title Board Seat Contact Info
Edward Truitt JD Chief Executive Officer & Co-Founder
Tannin Schmidt Ph.D Co-Founder & Senior Scientific Consultant
Gregory Jay Ph.D Co-Founder & Senior Medical Advisor
David Sullivan Ph.D Co-Founder & Senior Scientific Advisor
Edmund Pitcher JD Co-Founder & Board Member
You’re viewing 5 of 7 executive team members. Get the full list »

Lubris Board Members (3)

Name Representing Role Since
Benjamin Sullivan Ph.D Lubris Co-Founder, Scientific Advisor & Board Member 000 0000
Edmund Pitcher JD Lubris Co-Founder & Board Member 000 0000
Harry Barnett JD Self Co-Founder & Executive Chairman 000 0000
To view Lubris’s complete board members history, request access »

Lubris Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Lubris Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Tarnagulla Ventures Venture Capital Minority 000 0000 000000 0
Thynk Capital Venture Capital Minority 000 0000 000000 0
CONNECT (Accelerator) Accelerator/Incubator 000 0000 000000 0
JLABS Accelerator/Incubator 000 0000 000000 0
To view Lubris’s complete investors history, request access »